Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunity, the trophoblast and decidua]

E Aguilar Parada1, M Rábago Velasco, M T Aguilar Ibarra

  • 1Unidad de Investigación Biomédica, Hospital de Especialidades Centro Médico Nacional, IMSS, México, D.F.

Ginecologia Y Obstetricia De Mexico
|February 1, 1993
PubMed
Summary

The embryo evades maternal immune attack by producing trophoblastic protein-1, an interferon variant, which inhibits prostaglandin synthesis and suppresses T cell proliferation, ensuring pregnancy survival.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Premature ovarian insufficiency and nuclear organizer regions in triplicate].

Ginecologia y obstetricia de Mexico·1992
Same author

[Simultaneous identification of the nucleolar organizing regions and G bands in obstetrical cytogenetic studies].

Ginecologia y obstetricia de Mexico·1992
Same author

[Pancreatic beta cells and cytokines].

Gaceta medica de Mexico·1992
Same author

[Interleukins, interferon and the development of the endometrial epithelium].

Ginecologia y obstetricia de Mexico·1992
Same author

[The estrogen receptor in breast carcinoma in male patients and the tamoxifen response].

Ginecologia y obstetricia de Mexico·1988
Same author

Mathematical evaluation of research projects.

Archivos de investigacion medica·1982

Area of Science:

  • Reproductive immunology
  • Maternal-fetal interface immunology
  • Embryonic development and immune evasion

Context:

  • Pregnancy requires immune tolerance to prevent rejection of the semi-allogeneic conceptus.
  • The maternal immune system poses a significant threat to embryonic survival.
  • Specific molecular mechanisms are employed by the embryo to navigate this immune challenge.

Purpose:

  • To elucidate the molecular strategies utilized by the embryo to evade maternal immune surveillance.
  • To identify key proteins and signaling pathways involved in establishing and maintaining pregnancy.
  • To understand the consequences of failed immune evasion mechanisms on pregnancy outcome.

Summary:

  • The conceptus employs trophoblastic protein-1, an interferon variant, to inhibit prostaglandin F-2a synthesis, prolonging corpus luteum survival.

Related Experiment Videos

  • This protein, along with other interferons (IFN-b and IFN-g), prostaglandin E-2, and progesterone, collectively suppresses T cell proliferation and aids immune evasion.
  • Disruption of these immune-modulating mechanisms can lead to maternal killer T cell activation, conceptus infiltration, and pregnancy loss.

    • Impact:

    • Provides critical insights into the sophisticated immune-regulatory dialogue between mother and embryo.
    • Highlights potential therapeutic targets for managing pregnancy complications related to immune rejection.
    • Enhances understanding of reproductive success and failure at the immunological level.